Lyell Immunopharma Inc (NASDAQ:LYEL)

9.96
Delayed Data
As of 4:00pm ET
 +0.82 / +8.97%
Today’s Change
8.52
Today|||52-Week Range
19.84
--
Year-to-Date

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Lyell Immunopharma Inc have a median target of 25.00, with a high estimate of 31.00 and a low estimate of 22.00. The median estimate represents a +151.00% increase from the last price of 9.96.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Buy stock in Lyell Immunopharma Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.52
Sales
$2.7M
Reporting Date
TBD

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -154.83%
 
 
 
 
 
Growthannually --

Sales

Growthquarterly -3.04%
 
 
 
 
 
Growthannually --
Key to the earnings and sales forecast charts.